Isofol Medical Ownership
ISOFOL Stock | SEK 1.78 0.08 4.71% |
Isofol |
Isofol Stock Ownership Analysis
About 26.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.65. Some equities with similar Price to Book (P/B) outperform the market in the long run. Isofol Medical AB recorded a loss per share of 1.42. The entity had not issued any dividends in recent years. Isofol Medical AB , a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden. Isofol Medical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 12 people. To learn more about Isofol Medical AB call Gustaf MSc at 46 3 17 97 22 80 or check out https://isofolmedical.com.Isofol Medical Outstanding Bonds
Isofol Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Isofol Medical AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Isofol bonds can be classified according to their maturity, which is the date when Isofol Medical AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Isofol Stock
Isofol Medical financial ratios help investors to determine whether Isofol Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Isofol with respect to the benefits of owning Isofol Medical security.